Application & Function
SR-9009 is an agonist at nuclear receptor Rev-ErbA. Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model. SR-9009 suppresses atherosclerosis in a mouse model. Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues. Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.
Benefits:
Fat Loss
- Increases glucose metabolism
- Increases calorie metabolism
- Improves basal metabolic rate
- Reduced Inflammation
- Treatment for Obesity,Type II Diabetes,sarcopenia,Cholesterol-Related Conditions
Package & Trade Terms
Package: 25kg carton drum (32cm*58cm)or 1kg foil bag (10cm*15cm) or by request of clients
Storage Condition: 2-8°C
Supply Ability: 10000.00KG/Month
Trade Terms: FOB,CIF,CIP,EXW
Shipping Mode: By Sea,By Air
Shipping Port: Tianjin
Payment Terms: T/T,Western Union
